Calypso Biotech’s vision is to give new hope to patients suffering from severe gastro-intestinal diseases. Founded by Alain Vicari and Yolande Chvatchko in 2013, Calypso Biotech is backed by investors that include Eclosion SA, Gilde Healthcare, INKEF Capital, Johnson & Johnson Innovation, and M Ventures. Calypso Biotech is headquartered in Plan-les-ouates.
FOUNDED:
2013
INDUSTRY:
Biotechnology, Medical, Pharmaceutical
FOUNDERS:
Alain Vicari, Yolande Chvatchko
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
